Jan Nolta, PhD
banner
jannolta.bsky.social
Jan Nolta, PhD
@jannolta.bsky.social
Director, Cell and Gene Therapy at University of California Davis Health in Sacramento.
Editor of the journal Stem Cells.
#Firstgen #celltherapy #stemcells #GeneTherapy

https://orcid.org/0000-0003-4576-8542
Thank you Judge Lin!

“As a part of Friday’s ruling, Judge Lin said the defendants in the case, including Mr. Trump and an array of government agencies, could not link federal funding “to any measures” that would violate the First Amendment.”

www.nytimes.com/2025/11/14/u...
Judge Orders Trump Not to Threaten University of California’s Funding
www.nytimes.com
November 15, 2025 at 4:16 PM
Reposted by Jan Nolta, PhD
#NORDSummit: Lee Greenwood, whose 5-year-old daughter Noa was born with #CanavanDisease, a severe #GeneticDisorder found mainly among Ashkenazi Jews. In June 2022, the girl received lifesaving #GeneTherapy and is now developing normally.
@nordrare.bsky.social

#RareDisease #RareSky #MedSky
October 21, 2025 at 6:26 PM
Reposted by Jan Nolta, PhD
A new review highlights the advances in DNA nucleases and delivery vectors for in vivo #GeneTherapy, outlining key developments, challenges, and their future potential to treat diverse #Diseases. #medsky

#OpenAccess: www.sciencedirect.com/science/arti...
October 20, 2025 at 12:49 PM
Reposted by Jan Nolta, PhD
This Month on HemeHub: SCD and Gene Therapy

Join us as we explore advances in the treatment of #sicklecelldisease through #genetherapy, featuring pivotal trials of Lyfgenia and Casgevy.

Stay tuned for our upcoming session featuring Dr. John Tisdale, Senior Investigator at the NHLBI.
October 4, 2025 at 8:57 PM
Reposted by Jan Nolta, PhD
Congratulations to ⁦‪UniQure and to the #huntingtonsdisease community! 💙💜

www.uniqure.com/investors-me...
Press Releases | Investors & Media
Reimagining the future of healthcare through the power of gene therapy.
www.uniqure.com
September 24, 2025 at 2:21 PM
Congratulations to Brian Fury, our GMP Facility Director at UC Davis Health @ucdavis.bsky.social, and to all of the other recipients of these G-Rex grant awards from ScaleReady.

www.prnewswire.com/news-release...
ScaleReady Awards G-Rex® Grants to Support Cell and Gene Therapy Manufacturing in California
/PRNewswire/ -- ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation (NASDAQ: TECH) and CellReady, today announced that eight...
www.prnewswire.com
September 12, 2025 at 5:18 PM
Reposted by Jan Nolta, PhD
UC Davis & @ucsanfrancisco.bsky.social scientists completed a clinical trial on a new cancer drug for pet cats with squamous cell carcinoma. Researchers believe it will also be effective for humans with similar head and neck cancers. Read more about the clinical trial: ucdav.is/46dxcfM
September 2, 2025 at 6:54 PM
Momentary break for a much-needed palate cleanser. 🫠
Never knew these adorable creatures existed until this moment. (and nope, it is not AI- they are real! 🥰)
Piglet squids (genus Helicocranchia) are a genus of small cranchiids known for their goofy appearance. They have a rather large siphon that make them look like a pig with a snout.

Well I guess with their arms raised up cranchiid style, they look like a pig with a crazy hairdo.

#SQUIDtember
September 11, 2025 at 5:04 PM
I am so honored to be a part of this team. Thank you to the NIH for starting up their funding again. Please hang in there, fellow scientists!
health.ucdavis.edu/medical-scho...
Dream team to develop in utero gene editing therapy for a rare neurological genetic disorder
Professor Aijun Wang won a $3.2 million NIH grant to develop a cure to Dup15q syndrome using an in-utero gene editing formula.
health.ucdavis.edu
September 11, 2025 at 4:00 PM
Reposted by Jan Nolta, PhD
Want to collaborate with the International Brain Laboratory on your own project? We have funding to work with groups anywhere in the world to do new large-scale projects and we are looking for new partners! Learn more and apply: www.internationalbrainlab.com/ibl-core-apply
September 11, 2025 at 12:27 PM
House appropriators snub Kennedy, include mRNA vaccine funding in spending bill www.statnews.com/2025/09/10/m... via @statnews.com
House appropriators snub Kennedy, include mRNA vaccine funding in spending bill
Lawmakers have snubbed health secretary RFK Jr. by including an amendment in a spending bill mandating that an agency under his purview continue to research messenger RNA vaccines.
www.statnews.com
September 11, 2025 at 3:48 PM
Reposted by Jan Nolta, PhD
The regime halted all federal grants then told UC administration if they pay $1 billion they could have them back.
It’s like ransomware.
UC is a public university system and we cannot do this.
So, no grants = no research and labs will shut down.
Are we great yet?

dailybruin.com/2025/08/09/a...
'An attack on knowledge': UCLA researchers say lifesaving research is in jeopardy - Daily Bruin
Dr. Jerzy Kupiec-Weglinski has led organ transplant research at UCLA for nearly three decades. Kupiec-Weglinski, the vice chairman of basic science research in the David Geffen School of Medicine’s su...
dailybruin.com
August 10, 2025 at 1:06 PM
The regime halted all federal grants then told UC administration if they pay $1 billion they could have them back.
It’s like ransomware.
UC is a public university system and we cannot do this.
So, no grants = no research and labs will shut down.
Are we great yet?

dailybruin.com/2025/08/09/a...
'An attack on knowledge': UCLA researchers say lifesaving research is in jeopardy - Daily Bruin
Dr. Jerzy Kupiec-Weglinski has led organ transplant research at UCLA for nearly three decades. Kupiec-Weglinski, the vice chairman of basic science research in the David Geffen School of Medicine’s su...
dailybruin.com
August 10, 2025 at 1:06 PM
Trump administration violated impoundment law by canceling NIH grants, slowing new awards, GAO finds www.statnews.com/2025/08/05/g... via @statnews.com
Trump administration violated impoundment law by canceling NIH grants, slowing new awards, GAO finds
The Government Accountability Office found that the Trump administration, by abruptly canceling NIH grants, had violated a 1974 federal law
www.statnews.com
August 5, 2025 at 9:46 PM
Good morning and happy Saturday. Take a deep breath and keep riding those waves. 🙏
July 26, 2025 at 12:08 PM
Reposted by Jan Nolta, PhD
Stimulating immune cells in vitro is a common experimental lab model. We profiled 150K blood immune cells treated with 11 different stimuli to compare the effects. The data are freely available for researchers. See the preprint for our findings and to access the data 🧪 doi.org/10.1101/2025...
July 3, 2025 at 3:39 PM
Reposted by Jan Nolta, PhD
Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia. #Tcell #immunotherapy #organonachip 🧪https://www.nature.com/articles/s41551-025-01428-2
Bioengineered immunocompetent preclinical trial-on-chip tool enables screening of CAR T cell therapy for leukaemia - Nature Biomedical Engineering
An ex vivo organotypic and immunocompetent human leukaemia chip system is used for CAR T cell therapy modelling and screening of patient response.
www.nature.com
July 2, 2025 at 12:04 PM
Reposted by Jan Nolta, PhD
After spearheading a 34% cut in cancer mortality, the National Cancer Institute at the NIH is bleeding resources and staff and could see its budget cut by nearly 40%. kffhealthnews.org/news/article...
World’s Premier Cancer Institute Faces Crippling Cuts and Chaos - KFF Health News
After spearheading a 34% cut in cancer mortality, the National Cancer Institute at the NIH is bleeding resources and staff and could see its budget cut by nearly 40%.
kffhealthnews.org
July 9, 2025 at 1:52 PM
Reposted by Jan Nolta, PhD
Explore this gift article from The New York Times. You can read it for free without a subscription.

www.nytimes.com/2025/06/05/h...

And this is your new improved FDA. Into everyone’s medical life, a few charlatans must fall.
Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments
www.nytimes.com
June 5, 2025 at 6:50 PM
Reposted by Jan Nolta, PhD
"Specific targeting of brain endothelial cells using enhancer AAV vectors"
www.cell.com/neuron/fullt...

Xiangmin Xu & colleagues
@cp-neuron.bsky.social
Specific targeting of brain endothelial cells using enhancer AAV vectors
Velazquez-Rivera et al. have developed and validated a set of new BEC-enhancer AAV vectors that allow for selective genetic labeling of, and access to, brain endothelial cells (BECs). These useful too...
www.cell.com
May 22, 2025 at 4:41 PM